← feed

Is NCT03431610 results overdue?

Yes — results are overdue. Primary completion was 2018-05-11; the FDAAA-801 reporting deadline (2019-05-11) passed 2644 days ago and no results are posted on ClinicalTrials.gov.

A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis

NCT IDNCT03431610 ↗
SponsorNovan, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-05-11 (ACTUAL)
Reporting deadline2019-05-11 (completion + 365d)
Days overdue2644
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 53a5f5063d861ba7… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03431610. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →